Synovus Financial Corp. »

Galectin Therapeutics shares owned by Synovus Financial Corp.

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Synovus Financial Corp. from 13F filings

Historical chart of Synovus Financial Corp. investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Synovus Financial Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Synovus Financial Corp.

Quarter filed Position value Share count Share price at filing
2025-09-30 $203k 48k 4.24
2025-06-30 $101k 48k 2.11
2025-03-31 $59k 48k 1.22
2024-12-31 $62k 48k 1.29
2024-09-30 $132k 48k 2.75
2024-06-30 $109k 48k 2.26
2024-03-31 $115k 48k 2.39
2023-12-31 $80k 48k 1.66
2023-09-30 $92k 48k 1.92
2023-06-30 $69k 48k 1.44
2023-03-31 $101k 48k 2.10
2022-12-31 $54k 48k 1.13
2022-09-30 $78k 48k 1.63
2022-06-30 $63k 48k 1.31
2022-03-31 $77k 48k 1.60
2021-12-31 $99k 48k 2.06